HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice.

AbstractBACKGROUND & AIMS:
Mesenchymal stem cell (MSC) transplantation was shown to be effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully understood. We transplanted encapsulated human MSCs in two mouse models of liver fibrosis to determine the mechanisms behind the protective effect.
METHODS:
Human bone marrow-derived MSCs were microencapsulated in novel alginate-polyethylene glycol microspheres. In vitro, we analyzed the effect of MSC-conditioned medium on the activation of hepatic stellate cells and the viability, proliferation, cytokine secretion, and differentiation capacity of encapsulated MSCs. The level of fibrosis induced by bile duct ligation (BDL) or carbon tetrachloride (CCl4) was assessed after intraperitoneal transplantation of encapsulated MSCs, encapsulated human fibroblasts, and empty microspheres.
RESULTS:
MSC-conditioned medium inhibited hepatic stellate cell activation and release of MSC secreted anti-apoptotic (IL-6, IGFBP-2) and anti-inflammatory (IL-1Ra) cytokines. Viability, proliferation, and cytokine secretion of microencapsulated MSCs were similar to those of non-encapsulated MSCs. Within the microspheres, MSCs maintained their capacity to differentiate into adipocytes, chondrocytes, and osteocytes. 23% (5/22) of the MSC clones were able to produce anti-inflammatory IL-1Ra in vitro. Microencapsulated MSCs significantly delayed the development of BDL- and CCl4-induced liver fibrosis. Fibroblasts had an intermediate effect against CCl4-induced fibrosis. Mice transplanted with encapsulated MSCs showed lower mRNA levels of collagen type I, whereas levels of matrix metalloproteinase 9 were significantly higher. Human IL-1Ra was detected in the serum of 36% (4/11) of the mice transplanted with microencapsulated MSCs.
CONCLUSIONS:
MSC-derived soluble molecules are responsible for an anti-fibrotic effect in experimental liver fibrosis.
AuthorsRaphael P H Meier, Redouan Mahou, Philippe Morel, Jeremy Meyer, Elisa Montanari, Yannick D Muller, Panayiotis Christofilopoulos, Christine Wandrey, Carmen Gonelle-Gispert, Leo H Bühler
JournalJournal of hepatology (J Hepatol) Vol. 62 Issue 3 Pg. 634-41 (Mar 2015) ISSN: 1600-0641 [Electronic] Netherlands
PMID25450712 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Alginates
  • Culture Media, Conditioned
  • Cytokines
  • RNA, Messenger
  • Polyethylene Glycols
  • Carbon Tetrachloride
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse
Topics
  • Adult
  • Adult Stem Cells (transplantation)
  • Alanine Transaminase (blood)
  • Alginates
  • Animals
  • Aspartate Aminotransferases (blood)
  • Bile Ducts
  • Carbon Tetrachloride (toxicity)
  • Cell Proliferation
  • Cell Survival
  • Culture Media, Conditioned
  • Cytokines (metabolism)
  • Hepatic Stellate Cells (metabolism, pathology)
  • Heterografts
  • Humans
  • Ligation
  • Liver Cirrhosis, Experimental (metabolism, pathology, therapy)
  • Male
  • Matrix Metalloproteinase 9 (genetics)
  • Mesenchymal Stem Cell Transplantation (methods)
  • Mice
  • Mice, Inbred DBA
  • Microspheres
  • Polyethylene Glycols
  • RNA, Messenger (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: